awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26747566-C64B17DC-413D-406E-88D6-F960AE47C89A
Q26747566-C64B17DC-413D-406E-88D6-F960AE47C89A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26747566-C64B17DC-413D-406E-88D6-F960AE47C89A
Future directions for bone metastasis research - highlights from the 2015 bone and the Oncologist new updates conference (BONUS)
P2860
Q26747566-C64B17DC-413D-406E-88D6-F960AE47C89A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26747566-C64B17DC-413D-406E-88D6-F960AE47C89A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7ed59dd44f6ab1df9c7d4eda7430855eb3aada6a
P2860
A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases.